Cannabis-based medicines and pain: a review of potential synergistic and entourage effects
- PMID: 33703917
- DOI: 10.2217/pmt-2020-0110
Cannabis-based medicines and pain: a review of potential synergistic and entourage effects
Abstract
The recent legalization of medicinal cannabis in several jurisdictions has spurred the development of therapeutic formulations for chronic pain. Unlike pure delta-9-tetrahydrocannabinol (THC), full-spectrum products contain naturally occurring cannabinoids and have been reported to show improved efficacy or tolerability, attributed to synergy between cannabinoids and other components in the cannabis plant. Although 'synergy' indicates that two or more active compounds may produce an additive or combined effect greater than their individual analgesic effect, potentiation of the biological effect of a compound by related but inactive compounds, in combination, was termed the 'entourage effect'. Here, we review current evidence for potential synergistic and entourage effects of cannabinoids in pain relief. However, definitive clinical trials and in vitro functional studies are still required.
Keywords: cannabinoids; entourage effect; neuropathic; pain; terpenoids.
Plain language summary
Lay abstract Cannabis-based medicines have been used for millennia, and recent studies have identified their main constituents for pain relief, delta-9-tetrahydrocannabinol and cannabidiol (CBD). However, cannabis contains hundreds of other potentially active compounds, and their combined effects may underlie the reported preference of some patients for cannabinoid extracts, rather than pure delta-9-tetrahydrocannabinol. Further, cannabis-based drugs may interact with endocannabinoids, which are produced within the body and are related to the compounds found in cannabis. We have reviewed the evidence for cannabinoids in combination, and with other drugs, for pain relief. Although there is some evidence for an advantage of combinations, basic research and clinical studies are still required.
Similar articles
-
The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians.J Neuroimmune Pharmacol. 2022 Jun;17(1-2):318-333. doi: 10.1007/s11481-021-10010-x. Epub 2021 Aug 31. J Neuroimmune Pharmacol. 2022. PMID: 34467511
-
Understanding Cannabis-Based Therapeutics in Sports Medicine.Sports Health. 2020 Nov/Dec;12(6):540-546. doi: 10.1177/1941738120956604. Epub 2020 Sep 16. Sports Health. 2020. PMID: 32936058 Free PMC article. Review.
-
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.Headache. 2018 Jul;58(7):1139-1186. doi: 10.1111/head.13345. Headache. 2018. PMID: 30152161 Review.
-
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence.Curr Pain Headache Rep. 2015 Oct;19(10):50. doi: 10.1007/s11916-015-0524-x. Curr Pain Headache Rep. 2015. PMID: 26325482 Review.
-
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Headache. 2015 Jun;55(6):885-916. doi: 10.1111/head.12570. Epub 2015 May 25. Headache. 2015. PMID: 26015168 Review.
Cited by
-
Assessing the effectiveness of cannabidiol additive supplementation on canine behavior and cortisol levels.Heliyon. 2024 May 15;10(10):e31345. doi: 10.1016/j.heliyon.2024.e31345. eCollection 2024 May 30. Heliyon. 2024. PMID: 38803908 Free PMC article.
-
How Biodegradable Polymers Can be Effective Drug Delivery Systems for Cannabinoids? Prospectives and Challenges.Int J Nanomedicine. 2024 May 22;19:4607-4649. doi: 10.2147/IJN.S458907. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38799700 Free PMC article. Review.
-
Les données probantes et les recommandations sur le cannabis à des fins médicales chez les enfants.Paediatr Child Health. 2024 Apr 5;29(2):104-121. doi: 10.1093/pch/pxad077. eCollection 2024 May. Paediatr Child Health. 2024. PMID: 38586491 Review.
-
Medical cannabis for children: Evidence and recommendations.Paediatr Child Health. 2024 Apr 5;29(2):104-121. doi: 10.1093/pch/pxad078. eCollection 2024 May. Paediatr Child Health. 2024. PMID: 38586483 Review.
-
Healthy cats tolerate long-term daily feeding of Cannabidiol.Front Vet Sci. 2024 Jan 24;10:1324622. doi: 10.3389/fvets.2023.1324622. eCollection 2023. Front Vet Sci. 2024. PMID: 38327816 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical